OnabotulinumtoxinA successfully used as migraine prophylaxis during pregnancy: a case report
Abstract
Botulinum toxin (btx) received U.S. Food and Drug Administration approval for migraine treatment in 2010 with a pregnancy category C. There are minimal reports of its usage in pregnancy with no adverse effects; however, there are no reported cases of usage in a known pregnancy for the successful tre …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pregnancy
adult
female
case reports
Infant
newborn
pregnancy complications / prevention & control*
botulinum toxins
type a / therapeutic use*
pmid:24902141
doi:10.7205/milmed-d-13-00477
andrew y robinson
patrick m grogan
acetylcholine release inhibitors / therapeutic use*
apgar score
migraine disorders / prevention & control*
Access
Citation
ID:
261578
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
261578
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet